Latest filing published 30 Aug 2021 for Prelude Therapeutics Inc, €51k.
Filing timeline
BuySaleInsider track record
Peggy Scherle: trading record in brief
This profile gathers the share dealings of Peggy Scherle in Prelude Therapeutics Inc, where the filings describe the role as senior executive. The record holds 25 filings, for trades running from 7 April 2021 to 27 August 2021.
On the market, this insider has only sold: 17 sales, €1.9M in total. Outside the open market, there are 2 share grants and 6 option exercises.
On 30 August 2021 came the latest disclosure, an open-market sale for €51k in Prelude Therapeutics Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peggy Scherle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,700 shares@ US$35.192.6% of flowCommon StockSEC:0001209191-21-053867:1
- 6,014 shares@ US$1.430.4% of flowCommon StockSEC:0001209191-21-053867:2
- 2,700 shares@ US$35.324.1% of flowCommon StockSEC:0001209191-21-053867:3
- 2,707 shares@ US$36.234.2% of flowCommon StockSEC:0001209191-21-053867:4
- 607 shares@ US$37.081.0% of flowCommon StockSEC:0001209191-21-053867:5
- 1,700 shares@ US$1.435.3% of flowCommon StockSEC:0001209191-21-053867:0
- 1,728 shares@ US$1.430.1% of flowCommon StockSEC:0001209191-21-051885:1
- 2,286 shares@ US$35.073.5% of flowCommon StockSEC:0001209191-21-051885:2
- 558 shares@ US$1.892.3% of flowCommon StockSEC:0001209191-21-051885:0
- 19,320 shares@ US$35.4529.4% of flowCommon StockSEC:0001209191-21-048688:1
- 680 shares@ US$36.091.1% of flowCommon StockSEC:0001209191-21-048688:2
- 20,000 shares@ US$1.4362.0% of flowCommon StockSEC:0001209191-21-048688:0
- 3,964 shares@ US$40.306.7% of flowCommon StockSEC:0001209191-21-031847:1
- 5,836 shares@ US$41.1410.1% of flowCommon StockSEC:0001209191-21-031847:2
- 200 shares@ US$41.850.4% of flowCommon StockSEC:0001209191-21-031847:3
- 10,000 shares@ US$1.4330.4% of flowCommon StockSEC:0001209191-21-031847:0
- 4,630 shares@ US$1.430.3% of flowCommon StockSEC:0001209191-21-026875:0
- 1,417 shares@ US$36.972.2% of flowCommon StockSEC:0001209191-21-026875:1
- 875 shares@ US$37.721.4% of flowCommon StockSEC:0001209191-21-026875:2
- 669 shares@ US$38.971.1% of flowCommon StockSEC:0001209191-21-026875:3
- 1,669 shares@ US$39.572.8% of flowCommon StockSEC:0001209191-21-026875:4
- 15,370 shares@ US$1.430.9% of flowCommon StockSEC:0001209191-21-026294:0
- 8,289 shares@ US$39.0213.8% of flowCommon StockSEC:0001209191-21-026294:1
- 6,881 shares@ US$39.6311.6% of flowCommon StockSEC:0001209191-21-026294:2
- 200 shares@ US$40.300.3% of flowCommon StockSEC:0001209191-21-026294:3
25 of 25 declarations
